News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
180 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21956)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (243)
2 (71)
4 (13)
5 (208)
6 (219)
7 (196)
8 (217)
9 (66)
11 (10)
12 (147)
13 (179)
14 (161)
15 (149)
16 (59)
18 (5)
19 (123)
20 (157)
21 (145)
22 (146)
23 (65)
24 (1)
25 (5)
26 (148)
27 (167)
28 (180)
29 (149)
30 (99)
31 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
11
12
13
14
15
16
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Horizon Therapeutics plc Names Andy Pasternak Executive Vice President, Chief Business Officer
Current Executive Vice President and Chief Business Officer, Robert F. Carey, will Retire Effective Oct. 1.
August 28, 2019
·
3 min read
Policy
U.S. District Court Invalidates Amgen Patent Claims Targeting PCSK9
Court rules in favor of Regeneron and Sanofi in ongoing Praluent® (alirocumab) patent litigation
August 28, 2019
·
11 min read
Policy
Family Research Council Applauds HHS Notice of Violation Issued to University of Vermont Medical Center for Conscience Rights Violation
Family Research Council applauded the Department of Health and Human Services Office for Civil Rights for issuing a Notice of Violation against the University of Vermont Medical Center for unlawfully forcing a nurse to assist in an abortion.
August 28, 2019
·
1 min read
Business
Innovent Reports Interim Results for Fiscal Year 2019
Strong Launch of First Commercialized Product, Transformative Progress in Pipeline Expansion and Drug Development
August 28, 2019
·
16 min read
Business
EdiGENE Changes Name to Modalis Therapeutics
EdiGENE Corporation announced that the company has changed its name to Modalis Therapeutics Corporation.
August 28, 2019
·
1 min read
Job Trends
EcoGen Laboratories Creates Strategic Proprietary Extraction Equipment to Advance Supply Chain
EcoGen Laboratories, the leading vertically-integrated manufacturer and supplier of hemp-derived specialty ingredients in the United States, announced the advancement of their proprietary extraction equipment responsible for the company’s strategy behind advancing their supply chain.
August 28, 2019
·
3 min read
Business
Blink Health Opens New Headquarters To Accommodate Rapid Growth
Blink Health, the app that lets people get their prescription medications at much lower prices, announces today the opening of its new headquarters in New York City.
August 28, 2019
·
3 min read
Business
Merritt Hawkins Teams with MedChi, the Maryland State Medical Society on Physician Recruiting/Compensation Initiatives
Collaboration Brings Recruiting Market Expertise to MedChi Members
August 28, 2019
·
3 min read
Drug Development
Phase 3 Clinical Trial Evaluating Continuous Subcutaneous Carbidopa/Levodopa (ND0612) Initiated In The United States For Parkinson’s Disease With Motor Fluctuations
Phase 3 BouNDless study investigating the efficacy, safety and tolerability of ND0612, a potential non-surgical, subcutaneous continuous treatment, compared to oral immediate-release carbidopa/levodopa in people with Parkinson’s disease experiencing motor fluctuations.
August 28, 2019
·
5 min read
BioMidwest
Phillips-Medisize Highlights Innovations in Drug Delivery and Digital Health at Suzhou Dialogue 2019 in China on September 1-3
Phillips-Medisize provides a wide range of custom drug delivery devices, connected health solutions and end-to-end manufacturing services to Asian, European and U.S. pharmaceutical companies and has a proven, yet growing, presence in China.
August 28, 2019
·
3 min read
Previous
13 of 18
Next